SCHEMBL981608

SCHEMBL981608

O=C(Nc1ccccc1-c1nc2cccnc2s1)c1cc(N2CCOCC2)nc(-c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
TP53 P04637 1/20 0.46
HTT P42858 3/20 0.45
KDM4E B2RXH2 4/20 0.45
MAPK1 P28482 2/20 0.45
ALDH1A1 P00352 4/20 0.44
LMNA P02545 2/20 0.44
POLB P06746 1/20 0.44
ALOX15 P16050 1/20 0.44
HPGD P15428 2/20 0.43
TSHR P16473 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HSD17B10 Q99714 1/20 0.43
SCN9A Q15858 1/20 0.43
P2RY12 Q9H244 1/20 0.42
PIK3CA P42336 4/20 0.42
PIK3R1 P27986 1/20 0.42
MTOR P42345 1/20 0.42
PIK3CD O00329 2/20 0.42
PIK3CB P42338 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12923662 0.92 MAPT (0.50) MAPTTP53HTTKDM4EMAPK1
SCHEMBL985227 0.92 MAPT (0.47) MAPTTP53HTTKDM4EMAPK1
SCHEMBL12923243 0.90 MAPT (0.46) MAPTTP53HTTKDM4EMAPK1
SCHEMBL984238 0.89 MAPT (0.45) MAPTTP53HTTKDM4EMAPK1
Hydrochloric Acid SCHEMBL985167 0.89 MAPT (0.45) MAPTTP53HTTKDM4EMAPK1
SCHEMBL12923288 0.88 MAPT (0.46) MAPTTP53HTTKDM4EMAPK1
Hydrochloric Acid SCHEMBL983731 0.87 MAPT (0.46) MAPTTP53HTTKDM4EMAPK1
SCHEMBL12923258 0.87 MAPT (0.44) MAPTTP53HTTKDM4EMAPK1
Hydrochloric Acid SCHEMBL983883 0.87 MAPT (0.43) MAPTTP53HTTKDM4EMAPK1
SCHEMBL12923426 0.86 P2RY12 (0.45) MAPTTP53HTTKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
WO-2009061453-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTRIS PHARMACEUTICALS, INC. (US) 2009-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRT3, SIRT1, SIRT2 MAPT 550/4885TP53 515/4885HTT 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.